474 related articles for article (PubMed ID: 33800829)
1. How Macrophages Become Transcriptionally Dysregulated: A Hidden Impact of Antitumor Therapy.
Medvedeva GF; Kuzmina DO; Nuzhina J; Shtil AA; Dukhinova MS
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800829
[TBL] [Abstract][Full Text] [Related]
2. Targeting tumor-associated macrophages for cancer immunotherapy.
Shu Y; Cheng P
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188434. PubMed ID: 32956767
[TBL] [Abstract][Full Text] [Related]
3. Targeting tumor-associated macrophages to reverse antitumor drug resistance.
Li S; Sheng J; Zhang D; Qin H
Aging (Albany NY); 2024 May; 16(11):10165-10196. PubMed ID: 38787372
[TBL] [Abstract][Full Text] [Related]
4. Targeting tumor-associated macrophages as an antitumor strategy.
Cheng N; Bai X; Shu Y; Ahmad O; Shen P
Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy.
Zhang SY; Song XY; Li Y; Ye LL; Zhou Q; Yang WB
Pharmacol Res; 2020 Nov; 161():105111. PubMed ID: 33065284
[TBL] [Abstract][Full Text] [Related]
6. Nanomaterials in modulating tumor-associated macrophages and enhancing immunotherapy.
Liang C; Zhang Y; Wang S; Jiao W; Guo J; Zhang N; Liu X
J Mater Chem B; 2024 May; 12(20):4809-4823. PubMed ID: 38695349
[TBL] [Abstract][Full Text] [Related]
7. The IKZF1-IRF4/IRF5 Axis Controls Polarization of Myeloma-Associated Macrophages.
Mougiakakos D; Bach C; Böttcher M; Beier F; Röhner L; Stoll A; Rehli M; Gebhard C; Lischer C; Eberhardt M; Vera J; Büttner-Herold M; Bitterer K; Balzer H; Leffler M; Jitschin S; Hundemer M; Awwad MHS; Busch M; Stenger S; Völkl S; Schütz C; Krönke J; Mackensen A; Bruns H
Cancer Immunol Res; 2021 Mar; 9(3):265-278. PubMed ID: 33563611
[TBL] [Abstract][Full Text] [Related]
8. Extracts of Cordyceps sinensis inhibit breast cancer growth through promoting M1 macrophage polarization via NF-κB pathway activation.
Li J; Cai H; Sun H; Qu J; Zhao B; Hu X; Li W; Qian Z; Yu X; Kang F; Wang W; Zou Z; Gu B; Xu K
J Ethnopharmacol; 2020 Oct; 260():112969. PubMed ID: 32422358
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs: As Critical Regulators of Tumor- Associated Macrophages.
Chatterjee B; Saha P; Bose S; Shukla D; Chatterjee N; Kumar S; Tripathi PP; Srivastava AK
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992449
[TBL] [Abstract][Full Text] [Related]
10. Novel Opportunities for Cathepsin S Inhibitors in Cancer Immunotherapy by Nanocarrier-Mediated Delivery.
Fuchs N; Meta M; Schuppan D; Nuhn L; Schirmeister T
Cells; 2020 Sep; 9(9):. PubMed ID: 32887380
[TBL] [Abstract][Full Text] [Related]
11. The Iron Curtain: Macrophages at the Interface of Systemic and Microenvironmental Iron Metabolism and Immune Response in Cancer.
DeRosa A; Leftin A
Front Immunol; 2021; 12():614294. PubMed ID: 33986740
[TBL] [Abstract][Full Text] [Related]
12. Activity of tumor-associated macrophage depletion by CSF1R blockade is highly dependent on the tumor model and timing of treatment.
O'Brien SA; Orf J; Skrzypczynska KM; Tan H; Kim J; DeVoss J; Belmontes B; Egen JG
Cancer Immunol Immunother; 2021 Aug; 70(8):2401-2410. PubMed ID: 33511454
[TBL] [Abstract][Full Text] [Related]
13. BAG3 in Tumor Resistance to Therapy.
De Marco M; Turco MC; Marzullo L
Trends Cancer; 2020 Dec; 6(12):985-988. PubMed ID: 32718905
[TBL] [Abstract][Full Text] [Related]
14. Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors.
Kes MMG; Van den Bossche J; Griffioen AW; Huijbers EJM
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188427. PubMed ID: 32961257
[TBL] [Abstract][Full Text] [Related]
15. Tumor-regulated macrophage type 2 differentiation promotes immunosuppression in laryngeal squamous cell carcinoma.
Zhang P; Zhang Y; Wang L; Lou W
Life Sci; 2021 Feb; 267():118798. PubMed ID: 33220295
[TBL] [Abstract][Full Text] [Related]
16. TFEB is a master regulator of tumor-associated macrophages in breast cancer.
Li Y; Hodge J; Liu Q; Wang J; Wang Y; Evans TD; Altomare D; Yao Y; Murphy EA; Razani B; Fan D
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32487570
[TBL] [Abstract][Full Text] [Related]
17. The Metabolic Features of Tumor-Associated Macrophages: Opportunities for Immunotherapy?
Mojsilovic SS; Mojsilovic S; Villar VH; Santibanez JF
Anal Cell Pathol (Amst); 2021; 2021():5523055. PubMed ID: 34476174
[TBL] [Abstract][Full Text] [Related]
18. Emerging Nanoparticle Strategies for Modulating Tumor-Associated Macrophage Polarization.
Shi L; Gu H
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944555
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Associated Macrophages: Critical Players in Drug Resistance of Breast Cancer.
Xiao M; He J; Yin L; Chen X; Zu X; Shen Y
Front Immunol; 2021; 12():799428. PubMed ID: 34992609
[TBL] [Abstract][Full Text] [Related]
20. Revisiting of TAMs in tumor immune microenvironment: Insight from NF-κB signaling pathway.
He R; He Y; Du R; Liu C; Chen Z; Zeng A; Song L
Biomed Pharmacother; 2023 Sep; 165():115090. PubMed ID: 37390708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]